These data suggest that CNG of EGFR and HER2 may be involved in radiotherapy resistance in gliomas, while CNG of HER3 and HER4 may be used as predictors for the sensitivity of glioma cells to chemotherapy. This evidence concerns the gene ERBB2 and central nervous system cancer.